We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$6.4B
AUM Growth
-$2.54B
Cap. Flow
-$4.01B
Cap. Flow %
-62.59%
Top 10 Hldgs %
10.01%
Holding
3,256
New
265
Increased
414
Reduced
957
Closed
1,193

Sector Composition

Rank Sector Weight
1 Financials 12.67%
2 Industrials 8.91%
3 Healthcare 8.02%
4 Technology 6.77%
5 Utilities 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSIQ icon
801
Canadian Solar
CSIQ
$1.02B
$1.01M 0.02%
+32,537
New +$1.09M
URA icon
802
Global X Uranium ETF
URA
$5.42B
$1M 0.02%
50,000
-62,500
-56% -$1.26M
ZM icon
803
Zoom
ZM
$28.2B
$1M 0.02%
14,798
+12,045
+438% +$915K
ESTC icon
804
Elastic
ESTC
$6.84B
$1M 0.02%
19,462
-624
-3% -$37.4K
EMLC icon
805
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$993K 0.02%
+41,000
New +$963K
F icon
806
Ford
F
$58.5B
$993K 0.02%
85,377
-148,922
-64% -$1.91M
ICE icon
807
Intercontinental Exchange
ICE
$85.6B
$991K 0.02%
9,657
-16,457
-63% -$1.64M
SAVE
808
DELISTED
Spirit Airlines, Inc.
SAVE
$990K 0.02%
50,808
-6,183
-11% -$127K
MTN icon
809
Vail Resorts
MTN
$5.32B
$989K 0.02%
4,151
+538
+15% +$126K
DELL icon
810
CALL
Dell
DELL
$262B
$985K 0.02%
24,500
-800
-3% -$31.6K
SRPT icon
811
Sarepta Therapeutics
SRPT
$1.57B
$985K 0.02%
7,603
+3,346
+79% +$388K
SEDG icon
812
SolarEdge
SEDG
$2.51B
$985K 0.02%
3,476
-6,512
-65% -$1.73M
INTU icon
813
Intuit
INTU
$86.5B
$984K 0.02%
2,528
-2,636
-51% -$1.05M
FCAX
814
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$981K 0.02%
97,168
-26,186
-21% -$263K
FMX icon
815
Fomento Económico Mexicano
FMX
$43.6B
$977K 0.02%
12,500
+8,208
+191% +$604K
JNJ icon
816
PUT
Johnson & Johnson
JNJ
$618B
$972K 0.02%
5,500
-13,800
-72% -$2.38M
GLW icon
817
Corning
GLW
$119B
$962K 0.02%
30,116
-39,080
-56% -$1.27M
ABBV icon
818
AbbVie
ABBV
$443B
$956K 0.01%
5,915
-3,333
-36% -$511K
BGS icon
819
B&G Foods
BGS
$287M
$956K 0.01%
+85,725
New +$1.19M
AONC
820
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$953K 0.01%
94,866
-88,025
-48% -$874K
SBNY
821
DELISTED
Signature Bank
SBNY
$951K 0.01%
8,254
+2,626
+47% +$361K
SPB icon
822
Spectrum Brands
SPB
$2.04B
$950K 0.01%
15,600
-3,969
-20% -$200K
AIG icon
823
American International
AIG
$41.7B
$950K 0.01%
15,027
-102,372
-87% -$5.96M
EBAY icon
824
eBay
EBAY
$50.6B
$950K 0.01%
22,899
-27,319
-54% -$1.13M
PATH icon
825
UiPath
PATH
$6.61B
$947K 0.01%
74,529
-24,790
-25% -$306K

Similar funds

Verition Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, Verition Fund Management held 3,256 positions worth $6.4B, down 28% from $8.94B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Verition Fund Management withdrew a net $4.01B in Q4 2022, closing 1,193 positions and reducing 957 holdings. Its most notable exit was Avalara, Inc., an estimated $73.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Verition Fund Management opened a new position in GFL Environmental Inc. Tangible Equity Units worth $35.7M.

  • Verition Fund Management's largest Q4 2022 buy was GFL Environmental Inc. Tangible Equity Units: 550,000 shares worth $35.7M.
  • Verition Fund Management added most to US Bancorp in Q4 2022, an estimated $42.3M increase.
  • Verition Fund Management's biggest Q4 2022 reduction was FirstEnergy, cutting an estimated $49.1M.
  • Verition Fund Management fully exited Avalara, Inc. in Q4 2022, selling an estimated $73.7M.
  • Verition Fund Management's ten largest holdings make up 10% of its $6.4B portfolio in Q4 2022.
  • Verition Fund Management opened 265 new positions and closed 1,193 in Q4 2022.
  • Verition Fund Management's portfolio value fell 28% quarter-over-quarter to $6.4B.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.